{"id":22195,"date":"2022-09-21T16:08:50","date_gmt":"2022-09-21T14:08:50","guid":{"rendered":"https:\/\/idibell.cat\/?p=22195"},"modified":"2022-09-22T09:59:20","modified_gmt":"2022-09-22T07:59:20","slug":"exit-del-segon-simposi-del-programa-de-recerca-oncobell","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2022\/09\/exit-del-segon-simposi-del-programa-de-recerca-oncobell\/","title":{"rendered":"\u00c8xit del segon simposi del programa de recerca Oncobell"},"content":{"rendered":"

Aquest dilluns i dimarts 19 i 20 de setembre s\u2019ha celebrat el segon Simposi Oncobell a l’auditori de l’Hospital Universitari de Bellvitge. Sota el lema “construint ponts entre la ci\u00e8ncia, la medicina i les persones<\/em><\/strong>” el congr\u00e9s \u00e9s un f\u00f2rum per a discutir els \u00faltims aven\u00e7os en recerca b\u00e0sica i cl\u00ednica amb professionals de primer nivell del c\u00e0ncer. En l’edici\u00f3 d’aquest any, hi han participat investigadors i investigadores de l’IDIBELL i d’altres centres de recerca nacionals i internacionals.<\/p>\n

La Dra. Mariosol Soengas<\/strong>, del CNIO de Madrid, ha estat l’encarregada d’iniciar el congr\u00e9s amb una sessi\u00f3 plen\u00e0ria sobre melanoma. Posteriorment, al llarg de tota la trobada han tingut lloc diverses sessions presidides per professionals de l’IDIBELL en les quals s\u2019ha aprofundit sobre temes com la gen\u00f2mica, la immunitat contra el c\u00e0ncer, les noves tecnologies cl\u00edniques, la met\u00e0stasi o el desenvolupament de resist\u00e8ncies al tractament. Per finalitzar les dues jornades, hem tingut el plaer d’escoltar al Dr. Alberto Bardelli<\/strong>, de la Universitat de Torino, parlar sobre la vigil\u00e0ncia immunol\u00f2gica en el c\u00e0ncer.<\/p>\n

Aquest \u00e9s el segon any que el programa de recerca en Mecanismes Moleculars i Ter\u00e0pia Experimental en Oncologia de l’IDIBELL organitza el Simposi Oncobell. Aquest programa format per 21 grups de recerca i 91 investigadors i investigadores principals lluita contra el c\u00e0ncer de manera col\u00b7lectiva i multidisciplin\u00e0ria, enfocant-se tant en els mecanismes moleculars com en les ter\u00e0pies experimentals.<\/p>\n

La Dra. Isabel Fabregat<\/strong> i el Dr. Josep Maria Piulats<\/strong>, tots dos coordinadors del programa Oncobell, declaren: “Creiem que estimular la comunicaci\u00f3 entre grups de recerca ens pot portar a construir millors idees que ens permetin traslladar el coneixement de la recerca b\u00e0sica a la cl\u00ednica m\u00e9s f\u00e0cilment<\/em>“.<\/p>\n

 <\/p>\n

 <\/p>\n

L\u2019Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l’Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l’Institut Catal\u00e0 de la Salut, l’Institut Catal\u00e0 d’Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n

L\u2019IDIBELL \u00e9s membre del Campus d’Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L’any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Aquest dilluns i dimarts 19 i 20 de setembre s\u2019ha celebrat el segon Simposi Oncobell a l’auditori de l’Hospital Universitari de Bellvitge. Sota el lema “construint ponts entre la ci\u00e8ncia, la medicina i les persones” el congr\u00e9s \u00e9s un f\u00f2rum per a discutir els \u00faltims aven\u00e7os en recerca b\u00e0sica i cl\u00ednica amb professionals de primer nivell del c\u00e0ncer<\/p>\n","protected":false},"author":8,"featured_media":22196,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[332,447],"tags":[],"publishpress_future_action":{"enabled":false,"date":"2024-05-13 01:28:00","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/22195"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=22195"}],"version-history":[{"count":1,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/22195\/revisions"}],"predecessor-version":[{"id":22197,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/22195\/revisions\/22197"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/22196"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=22195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=22195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=22195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}